Disease‐related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34414
Abstract: Thrombocytopenia in patients with myelofibrosis (MF) is prognostically detrimental and poses a therapeutic challenge. MF patients with thrombocytopenia are considered high‐risk by most prognostic models and their distinct phenotype has given rise to the emerging… read more here.
Keywords: related thrombocytopenia; distinct genetic; disease related; thrombocytopenia myelofibrosis ... See more keywords